BioLargo, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 6/16/2017
Contact Info
  • 14921 Chestnut St
  • Westminster, CA 92683

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000880242
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2800 - Chemicals & Allied Products
Incorporated In: DE, USA
Year of Inc. 1987
Employees 19 a/o Jun 15, 2017
Company Officers/Contacts
Dennis Calvert President, CEO, IR
Charles Dargan II CFO
Joseph Provenzano Secretary
Kenneth Code CSO
AJ Sexton V Director, Bus. Dev.
John Browning General Counsel
Company Directors
Dennis Calvert
Gary Cox Independent Director, Audit Committee Member, Compensation Committee Member
Kent C. Roberts II Independent Director
Dennis Marshall Independent Director, Audit Committee Member, Compensation Committee Member
Joseph Provenzano
Kent Roberts Independent Director
John S. Runyan Independent Director, Compensation Committee Member
Service Providers
Accounting/Auditing Firm
Haskell & White LLP
300 Spectrum Drive
Suite 300
Irvine, CA, 92618
United States
Securities Counsel

Not Available
Investor Relations Firm
UPTICK Newswire
10000 N 31st Ave
Suite C-105
Phoenix, AZ, 85051
United States
Company History
  • Formerly=NuWay Medical, Inc. until 3-07
  • Formerly=NuWay Energy, Inc. until 11-02
  • Formerly=Latin American Casinos, Inc. until 8-01
  • Formerly=Repossession Auction, Inc. to 6-94
BLGO Security Details
Share Structure
Market Value1 $49,286,839 a/o Oct 19, 2017
Authorized Shares 200,000,000 a/o May 19, 2017
Outstanding Shares 100,585,385 a/o Aug 11, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 65,557,822 a/o May 19, 2017
Par Value 0.00067
Shareholders of Record 653 a/o May 19, 2017
Short Selling Data
Short Interest 22,432 (165%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security